Skip to main content

Table 4 Univariate and multivariate logistic regression analysis of poor glycemic control (HbA1c ≥ 7.0%) in the study patients

From: Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease

Variable Univariate analysis Multivariate analysis
OR (95% CI) p value OR (95% CI) p value
Insulin therapy 5.70 (2.08–15.67) < 0.001   
n-6/n-3 ratio 2.69 (1.41–5.14) 0.003 4.35 (1.72–10.96) 0.002
hsCRP (mg/l) 1.28 (1.01–1.62) 0.043 1.52 (1.04–2.21) 0.032
Total n-6 PUFAs (µmol/l) 1.25 (1.04–1.50) 0.020   
T2DM duration (years) 1.11 (1.02–1.21) 0.019 1.18 (1.04–1.32) 0.008
C18:2; LA (µmol/l) 1.01 (1.001–1.011) 0.037   
C20:5; EPA (µmol/l) 0.98 (0.97–1.00) 0.050   
Total n-3 PUFAs (µmol/l) 0.76 (0.63–0.93) 0.007   
C-peptide (ng/ml) 0.66 (0.45–0.96) 0.028   
EPA/AA ratio 0.001 (0.0001–0.51) 0.034   
  1. AA arachidonic acid, CI confidence interval, EPA eicosapentaenoic acid, HbA 1c glycated hemoglobin, hsCRP high-sensitivity C-reactive protein, LA linoleic acid, PUFAs polyunsaturated fatty acids, OR odds ratio, T2DM type 2 diabetes mellitus